Interventions for Smoking Among Persons in Recovery
INSPIRE
A Stepped-Care Intervention for Current and Former Smokers in Outpatient Chemical Dependency Treatment
3 other identifiers
interventional
75
1 country
1
Brief Summary
Examine the efficacy of a stepped-care smoking cessation intervention for current and former smokers in chemical dependency treatment programs. We hypothesize that those who received the stepped-care intervention will be more likely to report smoking abstinence and drug or alcohol abstinence at 6 months.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2007
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2008
CompletedFirst Submitted
Initial submission to the registry
July 9, 2008
CompletedFirst Posted
Study publicly available on registry
July 14, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2009
CompletedMay 29, 2013
May 1, 2013
1.2 years
July 9, 2008
May 25, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
CO verified self-report 7-day smoking abstinence prior to assessment
6 months
Study Arms (2)
1
OTHERAssessment only + referral list to State quitline and smoking cessation education classes at Kaiser
2
EXPERIMENTALParticipants will receive self-help information handouts, expert system intervention that includes a stage-based manual and individualized written feedback reports plus in-person brief stage-appropriate counseling at baseline and 3-month assessment. Current smokers who indicate desire to quit smoking or former smokers who indicate high cravings for cigarettes will be offered nicotine replacement medications. Participants will receive three telephone counseling sessions delivered between baseline and 3 month at weeks 2, 4 and 8. As-needed telephone check-calls will be provided to participants on and 2 days after quit date, or to participants who have quit smoking and anticipate high risk situations.
Interventions
* stage-based expert system written intervention at baseline and 3 months * in-person stage appropriate counseling at baseline and 3 months * telephone counseling sessions at weeks 2,4 and 8, * as-needed brief check-in calls on or 2 days after quit date for those who have set a quit date; and/or check-in calls on days with anticipated high risk situations for former smokers or those who have quit smoking during the study * optional NRT nicotine replacement therapy in the forms of patch, gum or lozenge for current smokers who are ready to quit smoking and/or for former smokers who report significantly strong smoking urges
Referral list to smoking cessation classes at Kaiser and the California Smokers Helpline
Eligibility Criteria
You may qualify if:
- men and women
- over the age of 18
- currently enrolled in outpatient treatment program for drug and/or alcohol use and have received minimally 30 days of continuous treatment for drug and/alcohol in any outpatient treatment program(s) for drug and/or alcohol use for at least one month
- have regularly smoked cigarettes for at least one year in their lifetime
- have smoked within the past 5 years
You may not qualify if:
- clients with a life-threatening disease
- currently at imminent risk of committing suicide, or currently pregnant
- currently in treatment for nicotine dependence elsewhere
- cannot be reached by telephone (unable to provide a phone number where the participant can be reached directly
- non-English speakers.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of California, San Franciscolead
- Kaiser Permanentecollaborator
- National Institute on Drug Abuse (NIDA)collaborator
Study Sites (1)
Kaiser Permanente Central Diablo (Wlanut Creek/ Martinez)
Walnut Creek, California, 94596, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Janice Tsoh, PhD
University of California, San Francisco
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
July 9, 2008
First Posted
July 14, 2008
Study Start
April 1, 2007
Primary Completion
June 1, 2008
Study Completion
August 1, 2009
Last Updated
May 29, 2013
Record last verified: 2013-05